Evidence map›Paper›PMID 37338497›Full record

ReviewSingapore medical journal2025

The East Asian gut microbiome and its role in oncology: a narrative review.

Evelyn Yi Ting Wong, Jonathan Wei Jie Lee, Jeremy Fung Yen Lim, Han Chong Toh

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Singapore medical journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Recent advances in gastroenterology.Singapore medical journal · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Evelyn Yi Ting WongDivision of Medical Oncology, National Cancer Centre Singapore, Singapore.
Jonathan Wei Jie LeeAMILI Pte Ltd, Singapore.
Jeremy Fung Yen LimAMILI Pte Ltd, Singapore.
Han Chong TohDivision of Medical Oncology, National Cancer Centre Singapore, Singapore.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

abstractThe field of onco-microbiome is rapidly expanding. Multiple studies have shown the crucial role of gut microbiota in the regulation of nutrient metabolism, immunomodulation and protection against pathogens. Tools for manipulating the gut microbiota include dietary modification and faecal microbiota transfer. Accumulating evidence has also documented the application of specific intestinal microbiome in cancer immunotherapy, notably in enhancing the efficacy of immune checkpoint inhibitors. The aim of this review is to focus on the East Asian microbiome and to provide a current overview of microbiome science and its clinical application in cancer biology and immunotherapy.

Indexed as

Gastrointestinal MicrobiomeMedical OncologyNeoplasmsAsia, EasternEast Asian PeopleFecal Microbiota TransplantationHumansImmune Checkpoint InhibitorsImmunotherapyImmune Checkpoint InhibitorsCancer immunotherapyEast Asian microbiomegut microbiotamicrobiome modificationonco-microbes

Identifiers

PMID37338497
PMCPMC12404427

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.